INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND (IGF)-II, IGF-BINDING PROTEINS, AND IGF-BINDING PROTEIN PROTEASES ARE PRODUCED BY THECA AND STROMA OF NORMAL AND POLYCYSTIC HUMAN OVARIES
Hd. Mason et al., INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND (IGF)-II, IGF-BINDING PROTEINS, AND IGF-BINDING PROTEIN PROTEASES ARE PRODUCED BY THECA AND STROMA OF NORMAL AND POLYCYSTIC HUMAN OVARIES, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 276-284
There is increasing evidence for an important regulatory role for the
insulin-like growth factor (IGF) system in the human ovary. IGF-I and
-II and IGF-binding proteins (IGFBPs)-1 to -4 have been identified by
analysis of follicular fluid and granulosa cell-conditioned medium and
by in situ hybridization and Northern and dot blot analyses of ovaria
n tissues. It has been suggested that abnormalities of intraovarian IG
F-I or IGFBPs may play a part in the pathogenesis of polycystic ovary
syndrome. The aim of this study was to identify production of IGF-I an
d II and IGFBP-1 to -4 by unstimulated normal and polycystic ovaries.
IGF-I and -II were measured by RIA after acid-gel exclusion chromatogr
aphy in medium conditioned by incubation for 48 h with granulosa cells
or explants of theca or stroma. Both IGF-I and -II were present in th
e low nanograms per mt range in theca- and stroma-conditioned medium (
T+SCM). IGFBPs in T+SCM were initially analyzed by Western Ligand blot
ting, which revealed that low mol wt IGFBPs were predominant, especial
ly IGFBP-2 (35 kDa). There was a band corresponding to 26 kDa with sma
ller amounts of a 31-kDa band, but only a trace of IGFBP-3 (44 and 40
kDa, confirmed by immunoblot). We found no consistent differences betw
een normal and polycystic ovary syndrome ovaries, and although there w
as a trend toward increased IGFBP accumulation in response to LH, this
was not consistent. We were unable to detect IGFs or IGFBPs by Wester
n ligand blotting in granulosa cell-conditioned medium. In further stu
dies we attempted to measure IGFBP-3 by RIA using two different antise
ra (alpha-BP-3gl and 1287-2-14) that detect different epitopes of IGFB
P-3 and allow the presence of proteolytic activity to be demonstrated.
Results obtained using alpha-BP-3gl were lower than those using 1287-
2-14, suggesting proteolysis of IGFBP-3 in the medium. There was no ev
idence of proteolysis of serum IGFBP-3 after incubation with condition
ed medium, but in contrast, radiolabeled [I-125]IGFBP-3 was cleaved af
ter incubation with T+SCM. Immunoblotting revealed intact IGFBP-2 (35
kDa) and bands of various sizes between 16-33 kDa. Immunoreactive frag
ments of IGFBP-3 between 13-40 kDa were seen. In conclusion, T+SCM con
tained IGF-I and -II. IGFBP-2 and -4 were the predominant species of I
GFBP in T+SCM. T+SCM also contained significant protease activity dire
cted toward IGFBP-2 and -3. Proteolytic activity may be an important m
echanism by which bioactive IGFs are made available to these tissues.